Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Other Accumulated Expenses: 2021-2025

Historic Other Accumulated Expenses for BIO-TECHNE (TECH) over the last 5 years, with Jun 2025 value amounting to $1.6 million.

  • BIO-TECHNE's Other Accumulated Expenses rose 6.49% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 6.49%. This contributed to the annual value of $1.6 million for FY2025, which is 23.52% down from last year.
  • According to the latest figures from FY2025, BIO-TECHNE's Other Accumulated Expenses is $1.6 million, which was down 23.52% from $2.2 million recorded in FY2024.
  • BIO-TECHNE's 5-year Other Accumulated Expenses high stood at $3.9 million for FY2021, and its period low was $1.2 million during FY2022.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $1.6 million (2025), whereas its average is $1.7 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 68.05% in 2022, then skyrocketed by 52.23% in 2024.
  • Yearly analysis of 5 years shows BIO-TECHNE's Other Accumulated Expenses stood at $3.9 million in 2021, then tumbled by 68.05% to $1.2 million in 2022, then increased by 13.68% to $1.4 million in 2023, then soared by 52.23% to $2.2 million in 2024, then fell by 23.52% to $1.6 million in 2025.